First Green Spirit RX Medicinal Cannabis Dispensary Opens in Puerto Rico

DORADO, Puerto Rico, April 04, 2018 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or, the “Company”) announced today that it has officially opened its first medicinal cannabis dispensary in Dorado, located about 15 miles west of San Juan on Puerto Rico’s northern coast, and is currently serving both local and visiting patients holding valid Medicinal Cannabis Regulatory Board (“MCRB”) cards.  This marks an important milestone for Green Spirit as it continues to deliver on its mission to provide patients access to an extensive selection of top quality and reliable medicinal cannabis products in a safe, compassionate and knowledgable environment.

“This day has been long-awaited, and we are very happy to open the doors to the first Green Spirit RX medicinal cannabis dispensary in Puerto Rico,” said Les Ball, CEO of Green Spirit.  “We have created a safe, secure, beautiful and comfortable space for patients to visit, where licensed, knowledgeable and trained staff offer patients private consultations. Green Spirit RX welcomes patients holding valid MCRB cards.”

Visitors from the U.S. holding a valid registration for medicinal cannabis use in their home state can apply to obtain a temporary card from the MCRB in San Juan in order to purchase medicinal cannabis from dispensaries in Puerto Rico.

The new Green Spirit RX medicinal cannabis dispensary is located at the Paseo del Plata Shopping Center, Building No. 3, P.R. 696, int. José Efrón Avenue, Dorado, Puerto Rico 00646. Dorado, a popular tourist destination, is home to a number of golf courses, beaches and luxury hotels, including Dorado Beach – A Ritz-Carlton Reserve, the Caribbean’s only 2017 Forbes Five-Star Hotel and Spa award winner.  Dorado is also home to upscale neighborhoods and a picturesque central square.  Dorado Beach East is one of the islands most sought-after luxury residential areas, and home to some of Puerto Rico’s most exclusive neighborhoods and multi-million dollar residences.

The Company anticipates completing construction and commencing operations at its remaining locations by the end of the third quarter of 2018, upon receipt of the requisite establishment licenses from the Department of Health of Puerto Rico.

For more information about Green Spirit, visit the Company’s website at http://www.greenspiritrx.com/.

About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products.

Forward-Looking Statements                                                                                                 
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.

Contact:                                
Paul Gendreau
PGPR
[email protected]
678-807-7945